In vitro and in vivo antitumor efficacy of docetaxel and sorafenib combination in human pancreatic cancer cells.

Current cancer drug targets

Volumn 10, Issue 6, 2010, Pages 600-610

  Ulivi, P ^a   Arienti, C ^b   Zoli, W ^b   Scarsella, M ^b   Carloni, S ^b   Fabbri, F ^b   Tesei, A ^b   Chiadini, E ^b   Orlandi, A ^b   Passeri, D ^b   Zupi, G ^b   Milandri, C ^b   Silvestrini, R ^b   Amadori, D ^b   Leonetti, C ^b  

^a DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZENESULFONIC ACID DERIVATIVE; DOCETAXEL; PYRIDINE DERIVATIVE; SORAFENIB; TAXOID;

ANIMAL; APOPTOSIS; DRUG EFFECT; DRUG INTERACTION; HUMAN; PANCREAS TUMOR; PATHOLOGY; REVIEW; SURVIVAL RATE;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BENZENESULFONATES; DRUG INTERACTIONS; HUMANS; PANCREATIC NEOPLASMS; PYRIDINES; SURVIVAL RATE; TAXOIDS;

MLCS; MLOWN;

EID: 78049490844     PISSN: None     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/156800910791859489     Document Type: Review

References (0)